Briefing
Analytical validation of NeXT Personal, an ultra-sensitive personalized circulating tumor DNA assay.
The paper reports analytical validation of NeXT Personal, a tumor-informed ctDNA assay that uses whole-genome sequencing to track up to about 1,800 somatic variants.
- Design: Evidence level 3
- Assay: NeXT Personal